Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 7Completed 6Unknown 4Terminated 2Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Sarcoma 4Gynecologic 2

Conditions

Breast Neoplasms 1461Neoplasms 987Colorectal Neoplasms 823Carcinoma, Non-Small-Cell Lung 714Carcinoma, Hepatocellular 680Stomach Neoplasms 644Lung Neoplasms 575Prostatic Neoplasms 539Pancreatic Neoplasms 451Rectal Neoplasms 334Uterine Cervical Neoplasms 303Neoplasm Metastasis 294Colonic Neoplasms 291Ovarian Neoplasms 281Recurrence 278Esophageal Neoplasms 273Leukemia, Myeloid, Acute 251Head and Neck Neoplasms 239Multiple Myeloma 231Brain Neoplasms 204Polycystic Ovary Syndrome 198Nasopharyngeal Carcinoma 197Melanoma 195Precursor Cell Lymphoblastic Leukemia-Lymphoma 192Urinary Bladder Neoplasms 189Lymphoma 177Liver Neoplasms 175Endometrial Neoplasms 158Motor Activity 142Lymphoma, Large B-Cell, Diffuse 140

Interventions

olaparib 1cediranib 1apatinib 1Paclitaxel 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × OTHER × Carcinosarcoma × Clear all
NCT05537844 2022-09-23

BriTROC-2

Cancer Research UK, Glasgow

Unknown
250 enrolled
GynecologicSarcoma

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05265793 2022-03-04

Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma

Fudan University

Phase 2 Unknown
45 enrolled
Sarcoma

Carcinoma, Carcinosarcoma

NCT03570437 2022-03-02

COPELIA

University of Manchester

Phase 2 Unknown
124 enrolled
GynecologicSarcoma

Carcinosarcoma, Neoplasms, Endometrial Neoplasms

NCT05224999 2022-02-04

Nivolumab for Recurrent/Metastatic Carcinosarcoma

Yonsei University

Phase 2 Unknown
28 enrolled
Sarcoma

Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡